{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:26:06Z","timestamp":1794435966982,"version":"4.9.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R35CA220481"],"award-info":[{"award-number":["1R35CA220481"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["737988"],"award-info":[{"award-number":["737988"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acral and mucosal melanomas are aggressive subtypes of melanoma, which have a significantly lower burden of somatic mutations than cutaneous melanomas, but more frequent copy number variations, focused gene amplifications, and structural alterations. The landscapes of their genomic alterations remain to be fully characterized.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We compiled sequencing data of 240 human acral and mucosal melanoma samples from 11 previously published studies and applied a uniform pipeline to call tumor cell content, ploidy, somatic and germline mutations, as well as CNVs, LOH, and SVs. We identified genes that are significantly mutated or recurrently affected by CNVs and implicated in oncogenesis. We further examined the difference in the frequency of recurrent pathogenic alterations between the two melanoma subtypes, correlation between pathogenic alterations, and their association with clinical features.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We nominated <jats:italic>PTPRJ<\/jats:italic>, mutated and homozygously deleted in 3.8% (9\/240) and 0.8% (2\/240) of samples, respectively, as a probable tumor suppressor gene, and <jats:italic>FER<\/jats:italic> and <jats:italic>SKP2<\/jats:italic>, amplified in 3.8% and 11.7% of samples, respectively, as probable oncogenes. We further identified a long tail of infrequent pathogenic alterations, involving genes such as <jats:italic>CIC<\/jats:italic> and <jats:italic>LZTR1<\/jats:italic>. Pathogenic germline mutations were observed on <jats:italic>MITF<\/jats:italic>, <jats:italic>PTEN<\/jats:italic>, <jats:italic>ATM<\/jats:italic>, and <jats:italic>PRKN<\/jats:italic>. We found <jats:italic>BRAF<\/jats:italic> V600E mutations in acral melanomas with fewer structural variations, suggesting that they are distinct and related to cutaneous melanomas. Amplifications of <jats:italic>PAK1<\/jats:italic> and <jats:italic>GAB2<\/jats:italic> were more commonly observed in acral melanomas, whereas <jats:italic>SF3B1<\/jats:italic> R625 codon mutations were unique to mucosal melanomas (12.9%). Amplifications at 11q13-14 were frequently accompanied by fusion to a region on chromosome 6q12, revealing a recurrent novel structural rearrangement whose role remains to be elucidated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our meta-analysis expands the catalog of driver mutations in acral and mucosal melanomas, sheds new light on their pathogenesis and broadens the catalog of therapeutic targets for these difficult-to-treat cancers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13073-022-01068-0","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T23:05:26Z","timestamp":1655334326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-1026","authenticated-orcid":false,"given":"Meng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishani","family":"Banik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Hunter","family":"Shain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwei","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris C.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"1068_CR1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma. Cancer. 1998;83:1664\u201378.","journal-title":"Cancer"},{"key":"1068_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jaad.2016.08.007","volume":"76","author":"L Altieri","year":"2017","unstructured":"Altieri L, Wong MK, Peng DH, Cockburn M. Mucosal melanomas in the racially diverse population of California. J Am Acad Dermatol. 2017;76:250\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1068_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/bjd.15803","volume":"178","author":"Y Teramoto","year":"2018","unstructured":"Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, T\u00fcting T, et al. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. Br J Dermatol. 2018;178:443\u201351.","journal-title":"Br J Dermatol"},{"key":"1068_CR4","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1111\/jdv.16227","volume":"34","author":"I Cs\u00e1nyi","year":"2020","unstructured":"Cs\u00e1nyi I, Houshmand N, Sz\u0171cs M, \u00d3csai H, Kem\u00e9ny L, Ol\u00e1h J, et al. Acral lentiginous melanoma: a single-centre retrospective review of four decades in East-Central Europe. J Eur Acad Dermatol Venereol. 2020;34:2004\u201310.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1068_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2407-11-85","volume":"11","author":"Z Chi","year":"2011","unstructured":"Chi Z, Li S, Sheng X, Si L, Cui C, Han M, et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer. 2011;11:85.","journal-title":"BMC Cancer"},{"key":"1068_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jss.2020.02.010","volume":"251","author":"K Huang","year":"2020","unstructured":"Huang K, Fan J, Misra S. Acral lentiginous melanoma: incidence and survival in the United States, 2006-2015, an analysis of the SEER Registry. J Surg Res. 2020;251:329\u201339.","journal-title":"J Surg Res"},{"key":"1068_CR7","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135\u201347.","journal-title":"N Engl J Med"},{"key":"1068_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, et al. Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545:175\u201380.","journal-title":"Nature"},{"key":"1068_CR9","first-page":"1968","volume":"60","author":"BC Bastian","year":"2000","unstructured":"Bastian BC, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH, Br\u00f6cker E-B, et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 2000;60:1968\u201373 American Association for Cancer Research.","journal-title":"Cancer Res"},{"key":"1068_CR10","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1038\/s41467-019-11107-x","volume":"10","author":"F Newell","year":"2019","unstructured":"Newell F, Kong Y, Wilmott JS, Johansson PA, Ferguson PM, Cui C, et al. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets. Nat Commun. 2019;10:3163.","journal-title":"Nat Commun"},{"key":"1068_CR11","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1038\/s41467-020-18988-3","volume":"11","author":"F Newell","year":"2020","unstructured":"Newell F, Wilmott JS, Johansson PA, Nones K, Addala V, Mukhopadhyay P, et al. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. Nat Commun. 2020;11:5259 Nature Publishing Group.","journal-title":"Nat Commun"},{"key":"1068_CR12","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/jnci\/djz005","volume":"111","author":"I Yeh","year":"2019","unstructured":"Yeh I, Jorgenson E, Shen L, Xu M, North JP, Shain AH, et al. Targeted genomic profiling of acral melanoma. JNCI J Natl Cancer Inst. 2019;111:1068\u201377 Oxford Academic.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1068_CR13","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"R Akbani","year":"2015","unstructured":"Akbani R, Akdemir KC, Aksoy BA, Albert M, Ally A, Amin SB, et al. Genomic classification of cutaneous melanoma. Cell. 2015;161:1681\u201396.","journal-title":"Cell"},{"key":"1068_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1101\/gr.213348.116","volume":"27","author":"WS Liang","year":"2017","unstructured":"Liang WS, Hendricks W, Kiefer J, Schmidt J, Sekar S, Carpten J, et al. Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma. Genome Res. 2017;27:524\u201332.","journal-title":"Genome Res"},{"key":"1068_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/pcmr.12279","volume":"27","author":"SJ Furney","year":"2014","unstructured":"Furney SJ, Turajlic S, Stamp G, Thomas JM, Hayes A, Strauss D, et al. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Pigment Cell Melanoma Res. 2014;27:835\u20138.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1068_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/path.4204","volume":"230","author":"SJ Furney","year":"2013","unstructured":"Furney SJ, Turajlic S, Stamp G, Nohadani M, Carlisle A, Thomas JM, et al. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol. 2013;230:261\u20139.","journal-title":"J Pathol"},{"key":"1068_CR17","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1158\/1078-0432.CCR-18-3442","volume":"25","author":"R Zhou","year":"2019","unstructured":"Zhou R, Shi C, Tao W, Li J, Wu J, Han Y, et al. Analysis of mucosal melanoma whole-genome landscapes reveals clinically relevant genomic aberrations. Clin Cancer Res. 2019;25:3548\u201360.","journal-title":"Clin Cancer Res"},{"key":"1068_CR18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature11071","volume":"485","author":"MF Berger","year":"2012","unstructured":"Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature. 2012;485:502\u20136 Nature Publishing Group.","journal-title":"Nature"},{"key":"1068_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat J-P, et al. A landscape of driver mutations in melanoma. Cell. 2012;150:251\u201363.","journal-title":"Cell"},{"key":"1068_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EMV Allen","year":"2015","unstructured":"Allen EMV, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science. 2015;350:207\u201311 American Association for the Advancement of Science.","journal-title":"Science"},{"key":"1068_CR21","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","volume":"25","author":"D Liu","year":"2019","unstructured":"Liu D, Schilling B, Liu D, Sucker A, Livingstone E, Jerby-Arnon L, et al. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat Med. 2019;25:1916\u201327 Nature Publishing Group.","journal-title":"Nat Med"},{"key":"1068_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows\u2013Wheeler transform. Bioinformatics. 2010;26:589\u201395.","journal-title":"Bioinformatics"},{"key":"1068_CR23","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"1068_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213\u20139.","journal-title":"Nat Biotechnol"},{"key":"1068_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim S, Scheffler K, Halpern AL, Bekritsky MA, Noh E, K\u00e4llberg M, et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods. 2018;15:591\u20134.","journal-title":"Nat Methods"},{"key":"1068_CR26","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.","journal-title":"Nucleic Acids Res"},{"key":"1068_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward M-H, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29:308\u201311.","journal-title":"Nucleic Acids Res"},{"key":"1068_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"The 1000 Genomes Project Consortium","year":"2012","unstructured":"The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56\u201365.","journal-title":"Nature"},{"key":"1068_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1126\/science.1219240","volume":"337","author":"JA Tennessen","year":"2012","unstructured":"Tennessen JA, Bigham AW, O\u2019Connor TD, Fu W, Kenny EE, Gravel S, et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science. 2012;337:64\u20139 American Association for the Advancement of Science.","journal-title":"Science"},{"key":"1068_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Exome Aggregation Consortium, Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature"},{"key":"1068_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature"},{"key":"1068_CR32","doi-asserted-by":"publisher","first-page":"e1002384","DOI":"10.1371\/journal.pgen.1002384","volume":"7","author":"APJ de Koning","year":"2011","unstructured":"de Koning APJ, Gu W, Castoe TA, Batzer MA, Pollock DD. Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet. 2011;7:e1002384 Public Library of Science.","journal-title":"PLoS Genet"},{"key":"1068_CR33","doi-asserted-by":"crossref","unstructured":"Diossy M, Sztupinszki Z, Krzystanek M, Borcsok J, Eklund AC, Csabai I, et al. Strand Orientation Bias Detector (SOBDetector) to remove FFPE sequencing artifacts. bioRxiv. 2019:386417 Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/386417v2. Cited 2022 Mar 23.","DOI":"10.1101\/386417"},{"key":"1068_CR34","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena I, Raine KM, Gerstung M, Dawson KJ, Haase K, Van Loo P, et al. Universal patterns of selection in cancer and somatic tissues. Cell. 2017;171:1029\u20131041.e21.","journal-title":"Cell"},{"key":"1068_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41588-019-0572-y","volume":"52","author":"F Dietlein","year":"2020","unstructured":"Dietlein F, Weghorn D, Taylor-Weiner A, Richters A, Reardon B, Liu D, et al. Identification of cancer driver genes based on nucleotide context. Nat Genet. 2020;52:208\u201318 Nature Publishing Group.","journal-title":"Nat Genet"},{"key":"1068_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505:495\u2013501.","journal-title":"Nature"},{"key":"1068_CR37","doi-asserted-by":"crossref","unstructured":"Poplin R, Ruano-Rubio V, DePristo MA, Fennell TJ, Carneiro MO, Van der Auwera GA, et al. Scaling accurate genetic variant discovery to tens of thousands of samples. Genomics. 2017; Available from: http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/201178.","DOI":"10.1101\/201178"},{"key":"1068_CR38","doi-asserted-by":"publisher","unstructured":"Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J, Rudolph JE, Yaeger R, Soumerai T, Nissan MH, et al. OncoKB: a precision oncology knowledge base. JCO Precis Oncol. 2017. https:\/\/doi.org\/10.1200\/PO.17.00011.","DOI":"10.1200\/PO.17.00011"},{"key":"1068_CR39","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980\u20135.","journal-title":"Nucleic Acids Res"},{"key":"1068_CR40","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrc2210","volume":"7","author":"RL Levine","year":"2007","unstructured":"Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer. 2007;7:673\u201383.","journal-title":"Nat Rev Cancer"},{"key":"1068_CR41","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","volume":"27","author":"H Li","year":"2011","unstructured":"Li H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics. 2011;27:2987\u201393.","journal-title":"Bioinformatics"},{"key":"1068_CR42","doi-asserted-by":"publisher","unstructured":"Islam SMA, Wu Y, D\u00edaz-Gay M, Bergstrom EN, He Y, Barnes M, et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/2020.12.13.422570 Cold Spring Harbor Laboratory.","DOI":"10.1101\/2020.12.13.422570"},{"key":"1068_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Ng AWT, Wu Y, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578:94\u2013101 Nature Publishing Group.","journal-title":"Nature"},{"key":"1068_CR44","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen R, Seshan VE. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 2016;44:e131.","journal-title":"Nucleic Acids Res"},{"key":"1068_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","volume":"34","author":"AH Shain","year":"2018","unstructured":"Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, et al. Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution. Cancer Cell. 2018;34:45\u201355.e4.","journal-title":"Cancer Cell"},{"key":"1068_CR46","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. 2016;12:e1004873.","journal-title":"PLoS Comput Biol"},{"key":"1068_CR47","unstructured":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers | Genome Biology | Full Text. Available from: https:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/gb-2011-12-4-r41. Cited 2021 Jul 2."},{"key":"1068_CR48","doi-asserted-by":"publisher","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","volume":"28","author":"T Rausch","year":"2012","unstructured":"Rausch T, Zichner T, Schlattl A, St\u00fctz AM, Benes V, Korbel JO. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics. 2012;28:i333\u20139.","journal-title":"Bioinformatics"},{"key":"1068_CR49","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","volume":"30","author":"B Niu","year":"2014","unstructured":"Niu B, Ye K, Zhang Q, Lu C, Xie M, McLellan MD, et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics. 2014;30:1015\u20136.","journal-title":"Bioinformatics"},{"key":"1068_CR50","doi-asserted-by":"publisher","first-page":"e1007589","DOI":"10.1371\/journal.pgen.1007589","volume":"14","author":"WPD Hendricks","year":"2018","unstructured":"Hendricks WPD, Zismann V, Sivaprakasam K, Legendre C, Poorman K, Tembe W, et al. Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis. PLoS Genet. 2018;14:e1007589 Public Library of Science.","journal-title":"PLoS Genet"},{"key":"1068_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41467-018-08081-1","volume":"10","author":"K Wong","year":"2019","unstructured":"Wong K, van der Weyden L, Schott CR, Foote A, Constantino-Casas F, Smith S, et al. Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma. Nat Commun. 2019;10:353.","journal-title":"Nat Commun"},{"key":"1068_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng903","volume":"31","author":"CAL Ruivenkamp","year":"2002","unstructured":"Ruivenkamp CAL, van Wezel T, Zanon C, Stassen APM, Vlcek C, Csik\u00f3s T, et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet. 2002;31:295\u2013300 Nature Publishing Group.","journal-title":"Nat Genet"},{"key":"1068_CR53","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/ajmg.a.32930","volume":"149A","author":"P-W Chiang","year":"2009","unstructured":"Chiang P-W, Spector E, Scheuerle A. A case of Asian Indian OCA3 patient. Am J Med Genet A. 2009;149A:1578\u201380.","journal-title":"Am J Med Genet A"},{"key":"1068_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/12013","volume":"1","author":"AC Carrano","year":"1999","unstructured":"Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999;1:193\u20139.","journal-title":"Nat Cell Biol"},{"key":"1068_CR55","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1073\/pnas.081474898","volume":"98","author":"M Gstaiger","year":"2001","unstructured":"Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci. 2001;98:5043\u20138 National Academy of Sciences.","journal-title":"Proc Natl Acad Sci"},{"key":"1068_CR56","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1038\/onc.2013.277","volume":"32","author":"IA Ivanova","year":"2013","unstructured":"Ivanova IA, Vermeulen JF, Ercan C, Houthuijzen JM, Saig FA, Vlug EJ, et al. FER kinase promotes breast cancer metastasis by regulating \u03b16- and \u03b21-integrin-dependent cell adhesion and anoikis resistance. Oncogene. 2013;32:5582\u201392.","journal-title":"Oncogene"},{"key":"1068_CR57","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1158\/1541-7786.MCR-13-0003-T","volume":"11","author":"J Ahn","year":"2013","unstructured":"Ahn J, Truesdell P, Meens J, Kadish C, Yang X, Boag AH, et al. Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis. Mol Cancer Res. 2013;11:952\u201363 American Association for Cancer Research.","journal-title":"Mol Cancer Res"},{"key":"1068_CR58","doi-asserted-by":"publisher","first-page":"7968","DOI":"10.1073\/pnas.1105369108","volume":"108","author":"C Guo","year":"2011","unstructured":"Guo C, Stark GR. FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-\u03baB. Proc Natl Acad Sci. 2011;108:7968\u201373 National Academy of Sciences.","journal-title":"Proc Natl Acad Sci"},{"key":"1068_CR59","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1101\/gad.284166.116","volume":"30","author":"G Fan","year":"2016","unstructured":"Fan G, Zhang S, Gao Y, Greer PA, Tonks NK. HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer. Genes Dev. 2016;30:1542\u201357.","journal-title":"Genes Dev"},{"key":"1068_CR60","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1128\/MCB.23.7.2287-2297.2003","volume":"23","author":"J Piedra","year":"2003","unstructured":"Piedra J, Miravet S, Casta\u00f1o J, P\u00e1lmer HG, Heisterkamp N, Garc\u00eda de Herreros A, et al. p120 catenin-associated Fer and Fyn tyrosine kinases regulate \u03b2-catenin Tyr-142 phosphorylation and \u03b2-catenin-\u03b1-catenin interaction. Mol Cell Biol. 2003;23:2287\u201397 American Society for Microbiology.","journal-title":"Mol Cell Biol"},{"key":"1068_CR61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/exd.12080","volume":"22","author":"JA Puig-Butill\u00e9","year":"2013","unstructured":"Puig-Butill\u00e9 JA, Badenas C, Ogbah Z, Carrera C, Aguilera P, Malvehy J, et al. Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma. Exp Dermatol. 2013;22:148\u201350.","journal-title":"Exp Dermatol"},{"key":"1068_CR62","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1126\/science.aap7607","volume":"362","author":"M Steklov","year":"2018","unstructured":"Steklov M, Pandolfi S, Baietti MF, Batiuk A, Carai P, Najm P, et al. Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination. Science. 2018;362:1177\u201382 American Association for the Advancement of Science.","journal-title":"Science"},{"key":"1068_CR63","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/hmg\/ddy412","volume":"28","author":"M Motta","year":"2019","unstructured":"Motta M, Fidan M, Bellacchio E, Pantaleoni F, Schneider-Heieck K, Coppola S, et al. Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling. Hum Mol Genet. 2019;28:1007\u201322.","journal-title":"Hum Mol Genet"},{"key":"1068_CR64","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1158\/0008-5472.CAN-18-1045","volume":"78","author":"TF Eleveld","year":"2018","unstructured":"Eleveld TF, Schild L, Koster J, Zwijnenburg DA, Alles LK, Ebus ME, et al. RAS\u2013MAPK pathway-driven tumor progression is associated with loss of CIC and other genomic aberrations in neuroblastoma. Cancer Res. 2018;78:6297\u2013307.","journal-title":"Cancer Res"},{"key":"1068_CR65","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.24443","volume":"78","author":"V Gleize","year":"2015","unstructured":"Gleize V, Alentorn A, de K\u00e9rillis LC, Labussi\u00e8re M, Nadaradjane AA, Mundwiller E, et al. CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas. Ann Neurol. 2015;78:355\u201374.","journal-title":"Ann Neurol"},{"key":"1068_CR66","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature10539","volume":"480","author":"C Bertolotto","year":"2011","unstructured":"Bertolotto C, Lesueur F, Giuliano S, Strub T, de Lichy M, Bille K, et al. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature. 2011;480:94\u20138.","journal-title":"Nature"},{"key":"1068_CR67","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature10630","volume":"480","author":"S Yokoyama","year":"2011","unstructured":"Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V, et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature. 2011;480:99\u2013103.","journal-title":"Nature"},{"key":"1068_CR68","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1126\/science.1257216","volume":"347","author":"RL Flynn","year":"2015","unstructured":"Flynn RL, Cox KE, Jeitany M, Wakimoto H, Bryll AR, Ganem NJ, et al. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. Science. 2015;347:273\u20137.","journal-title":"Science"},{"key":"1068_CR69","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ng.356","volume":"41","author":"D Dankort","year":"2009","unstructured":"Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE Jr, et al. Braf V600E cooperates with Pten loss to induce metastatic melanoma. Nat Genet. 2009;41:544\u201352.","journal-title":"Nat Genet"},{"key":"1068_CR70","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","volume":"9","author":"BC Bastian","year":"2014","unstructured":"Bastian BC. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol Mech Dis. 2014;9:239\u201371.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"1068_CR71","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1021\/bi8020789","volume":"48","author":"Y Luo","year":"2009","unstructured":"Luo Y, Liang F, Zhang Z-Y. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1\/2 pathways. Biochemistry. 2009;48:1838\u201346 American Chemical Society.","journal-title":"Biochemistry"},{"key":"1068_CR72","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1750-3639.2010.00464.x","volume":"21","author":"A Petermann","year":"2011","unstructured":"Petermann A, Haase D, Wetzel A, Balavenkatraman KK, Tenev T, G\u00fchrs K-H, et al. Loss of the protein-tyrosine phosphatase DEP-1\/PTPRJ drives meningioma cell motility. Brain Pathol. 2011;21:405\u201318.","journal-title":"Brain Pathol"},{"key":"1068_CR73","doi-asserted-by":"publisher","first-page":"116553","DOI":"10.1016\/j.jns.2019.116553","volume":"408","author":"N Waldt","year":"2020","unstructured":"Waldt N, Scharnetzki D, Kesseler C, Kirches E, Stroscher N, B\u00f6hmer F-D, et al. Loss of PTPRJ\/DEP-1 enhances NF2\/Merlin-dependent meningioma development. J Neurol Sci. 2020;408:116553.","journal-title":"J Neurol Sci"},{"key":"1068_CR74","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/CMR.0000000000000345","volume":"27","author":"JD Hintzsche","year":"2017","unstructured":"Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, et al. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma. Melanoma Res. 2017;27:189\u201399.","journal-title":"Melanoma Res"},{"key":"1068_CR75","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/cancers11030419","volume":"11","author":"IA Ivanova","year":"2019","unstructured":"Ivanova IA, Arulanantham S, Barr K, Cepeda M, Parkins KM, Hamilton AM, et al. Targeting FER kinase inhibits melanoma growth and metastasis. Cancers. 2019;11:419 Multidisciplinary Digital Publishing Institute.","journal-title":"Cancers"},{"key":"1068_CR76","doi-asserted-by":"publisher","first-page":"e17578","DOI":"10.1371\/journal.pone.0017578","volume":"6","author":"G Chen","year":"2011","unstructured":"Chen G, Cheng Y, Zhang Z, Martinka M, Li G. Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival. PLoS One. 2011;6:e17578 Public Library of Science.","journal-title":"PLoS One"},{"key":"1068_CR77","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1021\/acsmedchemlett.8b00631","volume":"10","author":"T Taniguchi","year":"2019","unstructured":"Taniguchi T, Inagaki H, Baba D, Yasumatsu I, Toyota A, Kaneta Y, et al. Discovery of novel pyrido-pyridazinone derivatives as FER tyrosine kinase inhibitors with antitumor activity. ACS Med Chem Lett. 2019;10:737\u201342 American Chemical Society.","journal-title":"ACS Med Chem Lett"},{"key":"1068_CR78","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2013.06.048","volume":"154","author":"C-H Chan","year":"2013","unstructured":"Chan C-H, Morrow JK, Li C-F, Gao Y, Jin G, Moten A, et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell. 2013;154:556\u201368.","journal-title":"Cell"},{"key":"1068_CR79","doi-asserted-by":"crossref","unstructured":"Conway JR, Dietlein F, Taylor-Weiner A, AlDubayan S, Vokes N, Keenan T, et al. Integrated molecular drivers coordinate biological and clinical states in melanoma. Nat Genet. 2020;52:1373\u201383.","DOI":"10.1038\/s41588-020-00739-1"},{"key":"1068_CR80","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s43018-020-0077-8","volume":"1","author":"R Alkallas","year":"2020","unstructured":"Alkallas R, Lajoie M, Moldoveanu D, Hoang KV, Lefran\u00e7ois P, Lingrand M, et al. Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma. Nat Cancer. 2020;1:635\u201352 Nature Publishing Group.","journal-title":"Nat Cancer"},{"key":"1068_CR81","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","volume":"50","author":"J Armenia","year":"2018","unstructured":"Armenia J, Wankowicz SAM, Liu D, Gao J, Kundra R, Reznik E, et al. The long tail of oncogenic drivers in prostate cancer. Nat Genet. 2018;50:645\u201351.","journal-title":"Nat Genet"},{"key":"1068_CR82","doi-asserted-by":"publisher","first-page":"e2114753","DOI":"10.1001\/jamanetworkopen.2021.14753","volume":"4","author":"GY Ku","year":"2021","unstructured":"Ku GY, Kemel Y, Maron SB, Chou JF, Ravichandran V, Shameer Z, et al. Prevalence of germline alterations on targeted tumor-normal sequencing of esophagogastric cancer. JAMA Netw Open. 2021;4:e2114753.","journal-title":"JAMA Netw Open"},{"key":"1068_CR83","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/ng.491","volume":"42","author":"S Veeriah","year":"2010","unstructured":"Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, et al. Somatic mutations of the Parkinson\u2019s disease\u2013associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet. 2010;42:77\u201382.","journal-title":"Nat Genet"},{"key":"1068_CR84","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ajhg.2014.12.016","volume":"96","author":"D Xiong","year":"2015","unstructured":"Xiong D, Wang Y, Kupert E, Simpson C, Pinney SM, Gaba CR, et al. A recurrent mutation in PARK2 is associated with familial lung cancer. Am J Hum Genet. 2015;96:301\u20138.","journal-title":"Am J Hum Genet"},{"key":"1068_CR85","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-019-1646-9","volume":"574","author":"D Inoue","year":"2019","unstructured":"Inoue D, Chew G-L, Liu B, Michel BC, Pangallo J, D\u2019Avino AR, et al. Spliceosomal disruption of the non-canonical BAF complex in cancer. Nature. 2019;574:432\u20136.","journal-title":"Nature"},{"key":"1068_CR86","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","volume":"457","author":"CD Van Raamsdonk","year":"2009","unstructured":"Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O\u2019Brien JM, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi. Nature. 2009;457:599\u2013602.","journal-title":"Nature"},{"key":"1068_CR87","volume-title":"Mutations in GNA11 in uveal melanoma","author":"CD Van Raamsdonk","year":"2010","unstructured":"Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, et al. Mutations in GNA11 in uveal melanoma: Massachusetts Medical Society; 2010. https:\/\/doi.org\/10.1056\/NEJMoa1000584. Available from: https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1000584. Cited 2021 Sep 16"},{"key":"1068_CR88","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejca.2016.06.019","volume":"65","author":"X Sheng","year":"2016","unstructured":"Sheng X, Kong Y, Li Y, Zhang Q, Si L, Cui C, et al. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis. Eur J Cancer. 2016;65:156\u201363.","journal-title":"Eur J Cancer"},{"key":"1068_CR89","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","volume":"144","author":"DE Elder","year":"2020","unstructured":"Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway. Arch Pathol Lab Med. 2020;144:500\u201322.","journal-title":"Arch Pathol Lab Med"},{"key":"1068_CR90","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamadermatol.2021.0793","volume":"157","author":"KSM Smalley","year":"2021","unstructured":"Smalley KSM, Teer JK, Chen YA, Wu J-Y, Yao J, Koomen JM, et al. A mutational survey of acral nevi. JAMA Dermatol. 2021;157:831\u20135.","journal-title":"JAMA Dermatol"},{"key":"1068_CR91","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/s41556-021-00740-8","volume":"23","author":"RL Belote","year":"2021","unstructured":"Belote RL, Le D, Maynard A, Lang UE, Sinclair A, Lohman BK, et al. Human melanocyte development and melanoma dedifferentiation at single-cell resolution. Nat Cell Biol. 2021;23:1035\u201347.","journal-title":"Nat Cell Biol"},{"key":"1068_CR92","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/pcmr.12297","volume":"27","author":"N Okamoto","year":"2014","unstructured":"Okamoto N, Aoto T, Uhara H, Yamazaki S, Akutsu H, Umezawa A, et al. A melanocyte\u2013melanoma precursor niche in sweat glands of volar skin. Pigment Cell Melanoma Res. 2014;27:1039\u201350.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1068_CR93","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1755-148X.2011.00855.x","volume":"24","author":"EK Nishimura","year":"2011","unstructured":"Nishimura EK. Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation. Pigment Cell Melanoma Res. 2011;24:401\u201310.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1068_CR94","volume-title":"Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes","author":"M Wang","year":"2022","unstructured":"Wang M, Banik I, Shain AH, Yeh I, Bastian BC. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes: GitHub; 2022. https:\/\/github.com\/Bioinfowangm\/ac_mu_analysis"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01068-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-022-01068-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01068-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T23:06:36Z","timestamp":1655334396000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-022-01068-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1068"],"URL":"https:\/\/doi.org\/10.1186\/s13073-022-01068-0","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"16 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}